Yıl: 2020 Cilt: 4 Sayı: 2 Sayfa Aralığı: 199 - 203 Metin Dili: İngilizce DOI: 10.14744/ejmi.2020.15888 İndeks Tarihi: 15-10-2020

Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?

Öz:
Objectives: Despite the important improvements in prevention and treatment, febrile neutropenia is still a commonchallenge in patients with certain hematological disorders. Many biomarkers have been explored to identify high-riskneutropenic patients, which need hospitalization and broad-spectrum antibiotic treatment. In the present study, firstly,we aimed to investigate serum CRP, Chitotriosidase (CtH) and Neutrophil gelatinase-associated lipocalin level (NGAL) infebrile neutropenia, non-febrile neutropenia and control groups. Secondly, to evaluate the usefulness of CRP, CtH andNGAL as a inflammatory biomarker to detect slight inflammatory change associated with infection in these patients.Methods: This was a single center prospective study that investigated ChT and NGAL as a new biomarkers to detectslight inflammatory change associated with infection in febrile neutropenia, non-febrile neutropenia and controlgroups. Therefore, 168 serum samples, which were obtained from 26 patients with hematological disorders were dividedinto three groups; Febrile neutropenia, non-febrile neutropenia and control group.Results: The mean serum CRP, CtH and NGAL levels of febrile neutropenia group were significantly higher than theother two groups (p<0.05). However, there was not any statistically significant difference between non-febrile neutropeniaand control groups (P>0.05). C-reactive protein had a positive and significant correlation with CtH (r=0.548, p<0.05) and NGAL (r=0.311, p<0.05). Moreover, there was a positive and significant correlation between CtH and NGAL(r=0.247, p<0. 05). The area under the curve (AUC) values were found as 0.68 (0.48–0.79), 0.72 (0.56–0.87), 0.72 (0.56–0.87), 0.56 (0.39–0.66) for CRP, CtH and NGAL respectively and there was not any significant difference between any twoAUC values (p>0.05).Conclusion: Serum ChT level is the most sensitive and specific biomarker to detect slight inflammatory change associatedwith infection in febrile neutropenic patients. Therefore, in the future, it may be used instead of or in combination withCRP to discriminate critically ill patients, to prevent unnecessary hospitalization and antibiotic treatment in neutropenia.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik
  • 1. de Naurois J, Novitzky-Basso I, Gill MJ, Marti FM, Cullen MH, Roila F, et al. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol 2010;21:252–6. [CrossRef ]
  • 2. Hazan G, Ben-Shimol S, Fruchtman Y, Abu-Quider A, Kapelushnik J, Moser A, et al. Clinical and laboratory parameter dynamics as markers of blood stream infections in pediatric oncology patients with fever and neutropenia. J Pediatr Hematol Oncol 2014;36:275–9. [CrossRef ]
  • 3. Lappalainen M, Jokkala J, Juutilainen A, Hämäläinen S, Koivula I, Jantunen E, et al. Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics. Dis Markers 2018;12:6964529. [CrossRef ]
  • 4. Purkayastha K, Seth R, Amitabh S, Xess I, Kapil A and Sreenivas V. To Determine the Role of Procalcitonin in Febrile Neutropenic Episodes of Children Undergoing Treatment for Childhood Cancers. J Clin Case Reports 2016;6:4–8. [CrossRef ]
  • 5. la Martire G, Robin C, Oubaya N, Lepeule R, Beckerich F, Leclerc M, et al. De-escalation and discontinuation strategies in highrisk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome. Eur J Clin Microbiol Infect Dis 2018;37:1931–40. [CrossRef ]
  • 6. Sklavou R, Karavanaki K, Critselis E, Kossiva L, Giannaki M, Tsolia M, et al. Variation of serum C-reactive protein (CRP) over time in pediatric cancer patients with febrile illness and its relevance to identified pathogen. Clin Biochem 2012;45:1178– 82. [CrossRef ]
  • 7. Coskun O, Ozturk M, Erdem H, Gumral R, Yaman H, Karakas A, et al. Can chitotriosidase be a surrogate marker for invasive fungal disease? J Mycol Med 2012;22:256–60. [CrossRef ]
  • 8. Chiarla C, Giovannini I, Antuzzi D, Piras A, Ardito F, Giuliante F. Clinical use of plasma chitotriosidase in severe sepsis. Curr Med Res Opin 2016;32:273–6. [CrossRef ]
  • 9. Di Rosa M, Malaguarnera L. Chitotriosidase: A new inflammatory marker in diabetic complications. Pathobiology 2016;83:211–9. [CrossRef ]
  • 10. Roli L, Pecoraro V, Trenti T. Can NGAL be employed as prognostic and diagnostic biomarker in human cancers? A systematic review of current evidence. Int J Biol Markers 2017;32:53–61.
  • 11. Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A, et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Marker of Kidney Damage. Am J Kidney Dis 2008;52:595–605. [CrossRef ]
  • 12. Prat C, Sancho JM, Dominguez J, Xicoy B, Gimenez M, Ferra C, et al. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leuk Lymphoma 2008;49:1752–61.
  • 13. Michel CS, Teschner D, Wagner EM, Theobald M, Radsak MP. Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation. Ann Hematol 2017;96:2095–101. [CrossRef ]
  • 14. Strojnik K, Mahkovic-Hergouth K, Novakovic BJ, Seruga B. Outcome of severe infections in afebrile neutropenic cancer patients. Radiol Oncol 2016;50;442–8. [CrossRef ]
  • 15. Secmeer G, Devrim I, Kara A, Ceyhan M, Cengiz B, Kutluk T, et al. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia. J Pediatr Hematol Oncol 2007;29:107–11. [CrossRef ]
  • 16. Schuttrumpf S, Binder L, Hagemann T, Berkovic D, Trumper L, Binder C. Utility of procalcitonin concentration in the evaluation of patients with malignant diseases and elevated C-reactive protein plasma concentrations. Clin Infect Dis 2006;43:468–73. [CrossRef ]
  • 17. Massaro KS, Costa SF, Leone C, Chamone DA. Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect Dis 2007;22:137. [CrossRef ]
  • 18. Masoud M, Rudensky B, Elstein D, Zimran A. Chitotriosidase deficiency in survivors of Candida sepsis. Blood Cells Mol Dis 2002;29:116–8. [CrossRef ]
  • 19. Elmonem MA, Van Den Heuvel LP, Levtchenko EN. Immunomodulatory Effects of Chitotriosidase Enzyme. Enzyme Res 2016;16:17–20. [CrossRef ]
  • 20. Labadaridis I, Dimitriou E, Theodorakis M, Kafalidis G, Velegraki A, Michelakakis H. Chitotriosidase in neonates with fungal and bacterial infections. Arch Dis Child Fetal Neonatal Ed 2005;90:531–2. [CrossRef ]
  • 21. Firu SG, Streba CT, Firu D, Tache DE, Rogoveanu I. Neutrophil Gelatinase Associated Lipocalin (NGAL) – a biomarker of renal dysfunction in patients with liver cirrhosis: Do we have enough proof ? J Med Life 2015;8:15–20.
  • 22. Kim BK, Yim HE, Yoo KH. Plasma neutrophil gelatinase-associated lipocalin: a marker of acute pyelonephritis in children. Pediatr Nephrol 2017;32:477–84. [CrossRef ]
  • 23. Saleh NY, Abo El Fotoh WMM, El-Hawy MA. Serum Neutrophil Gelatinase-Associated Lipocalin: A Diagnostic Marker in Pediatric Sepsis. Pediatr Crit Care Med 2017;18:245–52. [CrossRef ]
  • 24. Suchojad A, Tarko A, Smertka M, Majcherczyk M, Brzozowska A, Wroblewska J, et al. Factors limiting usefulness of serum and urinary NGAL as a marker of acute kidney injury in preterm newborns. Ren Fail 2015;37:439–45. [CrossRef ]
  • 25. Basok BI, Kucur M. Increased chitotriosidase activities in patients with rheumatoid arthritis: a possible novel marker? J Med Biochem 2014;33:245–51. [CrossRef ]
APA KARTAL Ö, gürsel o, Eker İ, TAŞÇILAR M, Tapan S, kurekci a (2020). Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?. , 199 - 203. 10.14744/ejmi.2020.15888
Chicago KARTAL ÖMER,gürsel orhan,Eker İbrahim,TAŞÇILAR Mehmet,Tapan Serkan,kurekci ahmet emin Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?. (2020): 199 - 203. 10.14744/ejmi.2020.15888
MLA KARTAL ÖMER,gürsel orhan,Eker İbrahim,TAŞÇILAR Mehmet,Tapan Serkan,kurekci ahmet emin Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?. , 2020, ss.199 - 203. 10.14744/ejmi.2020.15888
AMA KARTAL Ö,gürsel o,Eker İ,TAŞÇILAR M,Tapan S,kurekci a Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?. . 2020; 199 - 203. 10.14744/ejmi.2020.15888
Vancouver KARTAL Ö,gürsel o,Eker İ,TAŞÇILAR M,Tapan S,kurekci a Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?. . 2020; 199 - 203. 10.14744/ejmi.2020.15888
IEEE KARTAL Ö,gürsel o,Eker İ,TAŞÇILAR M,Tapan S,kurekci a "Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?." , ss.199 - 203, 2020. 10.14744/ejmi.2020.15888
ISNAD KARTAL, ÖMER vd. "Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?". (2020), 199-203. https://doi.org/10.14744/ejmi.2020.15888
APA KARTAL Ö, gürsel o, Eker İ, TAŞÇILAR M, Tapan S, kurekci a (2020). Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?. Eurasian Journal of Medical Investigation, 4(2), 199 - 203. 10.14744/ejmi.2020.15888
Chicago KARTAL ÖMER,gürsel orhan,Eker İbrahim,TAŞÇILAR Mehmet,Tapan Serkan,kurekci ahmet emin Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?. Eurasian Journal of Medical Investigation 4, no.2 (2020): 199 - 203. 10.14744/ejmi.2020.15888
MLA KARTAL ÖMER,gürsel orhan,Eker İbrahim,TAŞÇILAR Mehmet,Tapan Serkan,kurekci ahmet emin Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?. Eurasian Journal of Medical Investigation, vol.4, no.2, 2020, ss.199 - 203. 10.14744/ejmi.2020.15888
AMA KARTAL Ö,gürsel o,Eker İ,TAŞÇILAR M,Tapan S,kurekci a Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?. Eurasian Journal of Medical Investigation. 2020; 4(2): 199 - 203. 10.14744/ejmi.2020.15888
Vancouver KARTAL Ö,gürsel o,Eker İ,TAŞÇILAR M,Tapan S,kurekci a Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?. Eurasian Journal of Medical Investigation. 2020; 4(2): 199 - 203. 10.14744/ejmi.2020.15888
IEEE KARTAL Ö,gürsel o,Eker İ,TAŞÇILAR M,Tapan S,kurekci a "Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?." Eurasian Journal of Medical Investigation, 4, ss.199 - 203, 2020. 10.14744/ejmi.2020.15888
ISNAD KARTAL, ÖMER vd. "Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?". Eurasian Journal of Medical Investigation 4/2 (2020), 199-203. https://doi.org/10.14744/ejmi.2020.15888